Liao Wei-Chih, Lin Cheng-Li, Shen Te-Chun, Tu Chih-Yen, Hsia Te-Chun, Hsu Wu-Huei
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
School of Medicine, China Medical University, Taichung, Taiwan.
Front Med (Lausanne). 2022 Apr 4;9:851573. doi: 10.3389/fmed.2022.851573. eCollection 2022.
Respiratory system infections commonly occur among individuals with asthma. However, whether asthma patients have a higher risk of pleural empyema development remains unclear.
This is a retrospective cohort study based on data from the National Health Insurance Research Database of Taiwan. The asthma cohort consisted of 48,360 newly diagnosed adult individuals from 2000 to 2012. The comparison cohort consisted of the same number of adults who did not have asthma and was matched for age, gender, comorbidity, and the year of diagnosis. The development of pleural empyema was followed up to 2013.
Pleural empyema incidence was 2.03-fold higher in the asthma cohort compared to the comparison cohort (8.65 vs. 4.25 per 10,000 person-years), with an adjusted hazard ratio (HR) of 2.12 [95% confidence interval (CI) = 1.76-2.56]. Stratified analyses by age, gender, comorbidity, and corticosteroid use revealed that the crude and adjusted HRs of pleural empyema associated with asthma were all significant. Among patients with asthma, the risk of pleural empyema elevated with increased frequency of annual asthma-related emergency room visits and hospital admissions (≥1 vs. <1, aHR = 8.07, 95% CI = 4.31-15.1 and aHR = 9.31, 95% CI = 5.56-15.6).
An increased risk of pleural empyema occurrence was observed in adult patients with asthma than those without asthma. Furthermore, the risk of pleural empyema may increase with poor control of asthma.
呼吸系统感染在哮喘患者中较为常见。然而,哮喘患者发生胸膜腔积脓的风险是否更高仍不清楚。
这是一项基于台湾国民健康保险研究数据库数据的回顾性队列研究。哮喘队列由2000年至2012年新诊断的48360名成年个体组成。对照队列由相同数量的无哮喘成年人组成,并按年龄、性别、合并症和诊断年份进行匹配。对胸膜腔积脓的发生情况随访至2013年。
哮喘队列中胸膜腔积脓的发病率比对照队列高2.03倍(每10000人年分别为8.65例和4.25例),调整后的风险比(HR)为2.12[95%置信区间(CI)=1.76 - 2.56]。按年龄、性别、合并症和皮质类固醇使用情况进行分层分析显示,与哮喘相关的胸膜腔积脓的粗风险比和调整后风险比均具有统计学意义。在哮喘患者中,胸膜腔积脓的风险随着每年哮喘相关急诊就诊和住院频率的增加而升高(≥1次与<1次相比,调整后风险比分别为8.07,95%CI = 4.31 - 15.1和调整后风险比为9.31,95%CI = 5.56 - 15.6)。
观察到成年哮喘患者发生胸膜腔积脓的风险高于无哮喘患者。此外,胸膜腔积脓的风险可能会随着哮喘控制不佳而增加。